Status:
COMPLETED
Prognostic Understanding in ESC (ProgESC Study)
Lead Sponsor:
University College, London
Conditions:
Advanced Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to assess how aware patients with advanced cancer are about their prognosis when they are referred to an Enhanced Supportive Care (ESC) service. Further, the study aim to assess the re...
Detailed Description
Background: Prognostic awareness among patients with life-limiting diseases has been shown to be associated with less depression, better quality of care and earlier referral to palliative care. Moreo...
Eligibility Criteria
Inclusion
- All participants aged 18 and older with advanced cancer referred to the ESC team will be eligible for this study.
Exclusion
- Younger than 18 years
- Insufficient English language to complete questionnaires
- cognitive impairment
- Participants who, in the opinion of the member of the ESC team, would not be appropriate to participate
Key Trial Info
Start Date :
November 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2024
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT06067087
Start Date
November 15 2023
End Date
August 31 2024
Last Update
January 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College Hospital Macmillan Cancer Centre
London, United Kingdom